☆ 4.6 Review

Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review

NEURO-ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients

Maria Diaz et al.

Summary: Brain tumor patients have a higher risk of VTE, and recent studies have identified new risk factors and molecular mechanisms associated with VTE in these patients. Anticoagulation is necessary for VTE treatment in brain tumor patients, and DOACs may be a feasible option.

CURRENT ONCOLOGY REPORTS (2022)

添加到收藏夹

Article Clinical Neurology

Venous thromboembolic events in glioblastoma patients: An epidemiological study

Amanda Eisele et al.

Summary: Background and purpose: This study aimed to assess the frequency, risk factors, and treatment of VTEs in glioblastoma patients. The results showed that VTEs occurred early in the disease course, suggesting that primary VTE prophylaxis could be explored during first-line chemoradiotherapy.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma

Alissa A. Thomas et al.

Summary: Patients with malignant gliomas (MG) have a high risk of developing VTE, but currently lack standard recommendations for long-term outpatient VTE prophylaxis due to insufficient clinical trial evidence. In this study, the use of apixaban as VTE prevention in patients shortly after craniotomy was found to be safe and effective, with no unacceptable toxicities reported.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

添加到收藏夹

Article Oncology

Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?

Jasmin Jo et al.

Summary: This study aimed to assess the risk of intracranial hemorrhage (ICH) in high-grade glioma (HGG) patients with venous thromboembolism (VTE) on low molecular weight heparin (LMWH). The retrospective matched cohort study found that therapeutic LMWH is not associated with a substantially increased risk of ICH in HGG patients, and the median survival was similar among all three cohorts.

NEURO-ONCOLOGY (2022)

添加到收藏夹

Article Hematology

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma

Fleur H. J. Kaptein et al.

Summary: This study assessed the incidence, predictors, and impact of venous thromboembolism (VTE), arterial thromboembolism (ATE), and major bleeding (MB) in glioblastoma patients. The study found a high incidence of VTE and MB, and both complications were associated with poorer prognosis.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Oncology

Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study

Lauren Reed-Guy et al.

Summary: DOACs are associated with a lower incidence of clinically relevant ICH in patients with GBM-associated VTE compared to LMWH.

NEURO-ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma

Yong Huang et al.

Summary: Applying a risk assessment model for VTE in IDH1wt GBM patients can identify those with high and low risk of VTE.

SUPPORTIVE CARE IN CANCER (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence

Stephan Nopp et al.

Summary: While anticoagulation therapy has made progress, thrombosis remains a leading cause of death worldwide. Direct oral anticoagulants dominate clinical practice, but bleeding risk is still significant. Therefore, research focuses on developing safer anticoagulants, with factor XI (FXI) inhibition as a promising target.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Direct oral anticoagulants toxicity in children: an overview and practical guide

Maryam Daei et al.

Summary: This article provides an overview and practical guide to DOAC-toxicity in pediatrics, helping clinicians and pharmacists become familiar with the clinical features and management strategies of DOAC-toxicity among pediatric population.

EXPERT OPINION ON DRUG SAFETY (2022)

添加到收藏夹

Review Hematology

ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis

Michela Giustozzi et al.

Summary: Anticoagulant treatment in patients with primary and metastatic brain cancer carries the risk of intracranial hemorrhage (ICH). Patients with metastatic brain cancer have a particularly high risk of ICH, while patients with primary brain cancer have an increased risk of ICH during anticoagulation. Compared to low-molecular weight heparin (LMWH), direct oral anticoagulants (DOACs) are associated with a lower risk of ICH.

BLOOD ADVANCES (2022)

添加到收藏夹

Article Hematology

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Andrew Dunbar et al.

Summary: This study identified that somatic tumor mutations of STK11, KRAS, CTNNB1, KEAP1, CDKN2B, and MET were associated with an increased risk of VTE in patients with solid tumors, highlighting the need for further validation and exploration of unique molecular signatures specific to individual tumor types.

BLOOD (2021)

添加到收藏夹

Article Clinical Neurology

Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype

Maria Diaz et al.

Summary: The study found that patients with lower-grade gliomas have a higher VTE risk, which is decreased in the presence of an IDH mutation. The incidence of VTE in glioblastoma patients is not affected by MGMT promoter methylation status.

NEUROLOGY (2021)

添加到收藏夹

Review Hematology

Cancer Therapy-Associated Thrombosis

Steven P. Grover et al.

Summary: Cancer patients are at a higher risk of arterial and venous thrombotic events compared to the general population, with factors such as cancer site and stage, treatment-related factors, and cytotoxic effects of chemotherapeutic agents contributing to this increased risk. Despite advancements in targeted therapies, some anticancer agents still carry a risk of thrombosis, necessitating a better understanding of the mechanisms involved to develop effective treatment strategies.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

添加到收藏夹

Article Oncology

Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?

Sina Burth et al.

Summary: During a follow-up of just under 9 months, anticoagulation did not appear to impact the incidence of intracranial hemorrhage in patients with glioblastoma or brain metastases.

JOURNAL OF NEURO-ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies

Andrew W. Swartz et al.

Summary: This study found that patients with brain tumors using DOACs experienced fewer major bleeding events compared to those using LMWH, with similar efficacy, suggesting that DOACs are a safe and effective treatment option for these patients.

ONCOLOGIST (2021)

添加到收藏夹

Article Hematology

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

Gary H. Lyman et al.

Summary: These evidence-based guidelines aim to support decision-making on the prevention and treatment of VTE in cancer patients, covering mechanical and pharmacological prophylaxis, as well as recommendations for initial, short-term, and long-term treatment based on patient risk and treatment circumstances. Recommendations vary depending on patient risk level and treatment situation.

BLOOD ADVANCES (2021)

添加到收藏夹

Article Hematology

Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis

Xia Wang et al.

Summary: The study revealed that high expression of PDPN in tumors is associated with an increased risk of VTE, inducing thrombosis through platelet activation. The anti-PDPN antibody SZ-168 can inhibit PDPN-induced platelet activation.

THROMBOSIS RESEARCH (2021)

添加到收藏夹

Article Hematology

Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles

Nadim Tawil et al.

Summary: This study found that PDPN and TF in GBM activate platelets and the clotting cascade through extracellular vesicles, promoting thrombosis, which could be potential targets for treatment.

BLOOD ADVANCES (2021)

添加到收藏夹

Article Oncology

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Nigel S. Key et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Hematology

Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Review Hematology

Novel antithrombotic strategies for treatment of venous thromboembolism

Jeffrey Weitz et al.

BLOOD (2020)

添加到收藏夹

Review Hematology

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Frits Mulder et al.

BLOOD (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Select Drug-Drug Interactions With Direct Oral Anticoagulants JACC Review Topic of the Week

Barbara S. Wiggins et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Clinical Neurology

Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage

Jose Orlando de Melo Junior et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease

John A. Kaufman et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Thrombotic Risk in Cancer Patients: Diagnosis and Management of Venous Thromboembolism

Rodolfo Citro et al.

JOURNAL OF CARDIOVASCULAR ECHOGRAPHY (2020)

添加到收藏夹

Article Hematology

Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis

Araci M. R. Rondon et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)

添加到收藏夹

Article Clinical Neurology

Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Gliomas in the Early Postoperative Period

Jun Watanabe et al.

WORLD NEUROSURGERY (2019)

添加到收藏夹

Review Hematology

Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin

Katsue Suzuki-Inoue

BLOOD (2019)

添加到收藏夹

Review Oncology

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Dominique Farge et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Letter Hematology

Safety of Primary Thromboprophylaxis Using Apixaban in Ambulatory Cancer Patients with Intracranial Metastatic Disease or Primary Brain Tumors

Sebastien Miranda et al.

THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Article Hematology

Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group

Menikae K. Heenkenda et al.

THROMBOSIS RESEARCH (2019)

添加到收藏夹

Review Hematology

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis

Frits I. Mulder et al.

HAEMATOLOGICA (2019)

添加到收藏夹

Article Hematology

Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors

B. J. Carney et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Article Hematology

Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells

Barbara Costa et al.

BLOOD ADVANCES (2019)

添加到收藏夹

Article Anesthesiology

European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery

David Faraoni et al.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2018)

添加到收藏夹

Article Oncology

Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis

Joeky T. Senders et al.

JOURNAL OF NEURO-ONCOLOGY (2018)

添加到收藏夹

Review Hematology

Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis

Steven P. Grover et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

添加到收藏夹

Article Oncology

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie M. Young et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Hematology

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

P. Mir Seyed Nazari et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

添加到收藏夹

Article Hematology

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

添加到收藏夹

Article Clinical Neurology

Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study.

Joeky T. Senders et al.

WORLD NEUROSURGERY (2018)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Inferior Vena Cava Filters to Prevent Pulmonary Embolism Systematic Review and Meta-Analysis

Behnood Bikdeli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

添加到收藏夹

Article Hematology

Management of venous thromboembolism in patients with glioma

Mosaad Al Megren et al.

THROMBOSIS RESEARCH (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Thrombosis in cancer patients: etiology, incidence, and management

Rahul A. Sheth et al.

CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)

添加到收藏夹

Article Hematology

Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin

Charlene Mantia et al.

BLOOD (2017)

添加到收藏夹

Article Hematology

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Julia Riedl et al.

BLOOD (2017)

添加到收藏夹

Article Clinical Neurology

Mutant IDH1 and thrombosis in gliomas

Dusten Unruh et al.

ACTA NEUROPATHOLOGICA (2016)

添加到收藏夹

Review Clinical Neurology

Venous thromboembolism in brain tumor patients

David J. Cote et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2016)

添加到收藏夹

Article Hematology

A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation

J. I. Zwicker et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Article Hematology

Recurrent venous thromboembolism in glioblastoma

Natasha Catherine Edwin et al.

THROMBOSIS RESEARCH (2016)

添加到收藏夹

Review Hematology

Current challenges in diagnostic imaging of venous thromboembolism

Menno V. Huisman et al.

BLOOD (2015)

添加到收藏夹

Review Oncology

Heparin in malignant glioma: review of preclinical studies and clinical results

Rosalie Schnoor et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

添加到收藏夹

Article Oncology

A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors

Michael B. Streiff et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Venous thromboembolism (VTE) and glioblastoma

Shlomit Yust-Katz et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

添加到收藏夹

Review Oncology

Venous thromboembolism in cancer patients: an underestimated major health problem

Jihane Khalil et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Risk of Adverse Vascular Events in Newly Diagnosed Glioblastoma Multiforme Patients Treated with Bevacizumab: a Systematic Review and Meta-Analysis

Xiaoqing Li et al.

SCIENTIFIC REPORTS (2015)

添加到收藏夹

Article Medicine, General & Internal

Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting

Patricia C. Silveira et al.

JAMA INTERNAL MEDICINE (2015)

添加到收藏夹

Article Oncology

Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period

Timothy R. Smith et al.

JOURNAL OF NEURO-ONCOLOGY (2014)

添加到收藏夹

Article Oncology

Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease

Kristopher T. Kimmell et al.

JOURNAL OF NEURO-ONCOLOGY (2014)

添加到收藏夹

Article Oncology

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas

Johannes Thaler et al.

NEURO-ONCOLOGY (2014)

添加到收藏夹

Article Medicine, General & Internal

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Letter Medicine, General & Internal

Bevacizumab for Newly Diagnosed Glioblastoma Reply

Olivier L. Chinot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Hematology

Thrombosis in Brain Tumors

Jasmin T. Jo et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)

添加到收藏夹

Article Education, Scientific Disciplines

Epidemiologic and clinical data linking factors XI and XII to thrombosis

Nigel S. Key

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)

添加到收藏夹

Article Medicine, General & Internal

Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma

Olivier L. Chinot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Review Hematology

Epidemiology of cancer-associated venous thrombosis

Jasmijn F. Timp et al.

BLOOD (2013)

添加到收藏夹

Letter Hematology

Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype

N. Magnus et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

P. Wang et al.

ONCOGENE (2013)

添加到收藏夹

Article Hematology

Non-OO blood type influences the risk of recurrent venous thromboembolism

Esteban Gandara et al.

THROMBOSIS AND HAEMOSTASIS (2013)

添加到收藏夹

Article Hematology

Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients

Johannes Thaler et al.

THROMBOSIS RESEARCH (2013)

添加到收藏夹

Article Oncology

Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients

Andrew D. Norden et al.

JOURNAL OF NEURO-ONCOLOGY (2012)

添加到收藏夹

Article Hematology

Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

J. Thaler et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

添加到收藏夹

Article Multidisciplinary Sciences

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

Sevin Turcan et al.

NATURE (2012)

添加到收藏夹

Article Oncology

Thromboembolic disease in patients with high-grade glioma

James R. Perry

NEURO-ONCOLOGY (2012)

添加到收藏夹

Article Hematology

Oncogenic regulation of tissue factor and thrombosis in cancer

Monika Anand et al.

THROMBOSIS RESEARCH (2012)

添加到收藏夹

Article Oncology

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Wei Xu et al.

CANCER CELL (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Rasheduzzaman Chowdhury et al.

EMBO REPORTS (2011)

添加到收藏夹

Article Critical Care Medicine

Valproic Acid and Warfarin: An Underrecognized Drug Interaction

Hyue W. Yoon et al.

NEUROCRITICAL CARE (2011)

添加到收藏夹

Article Hematology

Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells

Nathalie Magnus et al.

BLOOD (2010)

添加到收藏夹

Article Oncology

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

Houtan Noushmehr et al.

CANCER CELL (2010)

添加到收藏夹

Article Oncology

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Maria E. Figueroa et al.

CANCER CELL (2010)

添加到收藏夹

Article Oncology

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Roel G. W. Verhaak et al.

CANCER CELL (2010)

添加到收藏夹

Review Hematology

Venous thromboembolism in malignant gliomas

E. O. Jenkins et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

添加到收藏夹

Article Hematology

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

J. R. Perry et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

添加到收藏夹

Article Hematology

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

R. Simanek et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

添加到收藏夹

Article Hematology

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism

David A. Manly et al.

THROMBOSIS RESEARCH (2010)

添加到收藏夹

Article Oncology

Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

Jeffrey I. Zwicker et al.

CLINICAL CANCER RESEARCH (2009)

添加到收藏夹

Review Oncology

Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents

Maurizio Zangari et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

添加到收藏夹

Review Oncology

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

Alok A. Khorana et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang et al.

NATURE (2009)

添加到收藏夹

Article Hematology

Development and validation of a predictive model for chemotherapy-associated thrombosis

Alok A. Khorana et al.

BLOOD (2008)

添加到收藏夹

Article Oncology

Tissue Factor Regulation by Epidermal Growth Factor Receptor and Epithelial-to-Mesenchymal Transitions: Effect on Tumor Initiation and Angiogenesis

Chloe C. Milsom et al.

CANCER RESEARCH (2008)

添加到收藏夹

Review Hematology

The intrinsic pathway of coagulation:: a target for treating thromboembolic disease?

D. Gailani et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

添加到收藏夹

Article Oncology

Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer

Alok A. Khorana et al.

CLINICAL CANCER RESEARCH (2007)

添加到收藏夹

Article Oncology

Venous thromboembolism and survival in patients with high-grade glioma

Ralph Simanek et al.

NEURO-ONCOLOGY (2007)

添加到收藏夹

Article Clinical Neurology

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma

Thomas J. Semrad et al.

JOURNAL OF NEUROSURGERY (2007)

添加到收藏夹

Review Oncology

Management of venous thromboembolism in patients with primary and metastatic brain tumors

DE Gerber et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

添加到收藏夹

Article Medicine, General & Internal

Does this patient have deep vein thrombosis?

PS Wells et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

添加到收藏夹

Article Medicine, General & Internal

Incidence of venous thromboembolism in patients hospitalized with cancer

PD Stein et al.

AMERICAN JOURNAL OF MEDICINE (2006)

添加到收藏夹

Article Oncology

PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma

Y Rong et al.

CANCER RESEARCH (2005)

添加到收藏夹

Article Oncology

ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas

MB Streiff et al.

CANCER (2004)

添加到收藏夹

Article Medicine, General & Internal

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

AYY Lee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.